| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
7,094 |
6,890 |
$681K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,429 |
10,062 |
$650K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,105 |
5,082 |
$497K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,183 |
1,153 |
$115K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
944 |
919 |
$97K |
| 90723 |
|
3,535 |
3,509 |
$96K |
| 90670 |
|
3,781 |
3,751 |
$27K |
| 90647 |
|
3,298 |
3,281 |
$25K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
168 |
160 |
$19K |
| 99383 |
|
156 |
156 |
$18K |
| 90686 |
|
3,243 |
3,209 |
$18K |
| 90677 |
|
1,002 |
1,000 |
$10K |
| 90681 |
|
1,371 |
1,364 |
$10K |
| 90633 |
|
1,193 |
1,181 |
$9K |
| 99382 |
|
55 |
53 |
$6K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
59 |
59 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
93 |
90 |
$5K |
| 83655 |
|
375 |
371 |
$4K |
| 90707 |
|
174 |
174 |
$4K |
| 90656 |
|
308 |
308 |
$3K |
| 85018 |
|
1,021 |
998 |
$2K |
| 90700 |
|
97 |
97 |
$2K |
| 90716 |
|
181 |
181 |
$2K |
| 99384 |
|
12 |
12 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
26 |
26 |
$802.32 |
| 88738 |
|
130 |
128 |
$559.46 |
| 0081A |
|
14 |
13 |
$454.60 |
| 90651 |
|
59 |
49 |
$247.20 |
| 88720 |
|
69 |
55 |
$212.17 |
| 90734 |
|
24 |
14 |
$115.68 |